MedPage Today  Sep 19  Comment 
VIENNA (MedPage Today) -- Insulin glargine (Lantus) continued to carry no increased risk of cardiovascular events compared with standard care in an extension of the ORIGIN trial, researchers reported here.
Forbes  Sep 18  Comment 
Big Pharma’s onward race to tap biotech ingenuity in the face of its traditional and problematic large-scale R&D model has spurred new kinds of early-stage collaborations, ranging from Johnson & Johnson’s Innovation Centers to Pfizer’s...
FierceBiotech  Sep 18  Comment 
A little more than two months after inking a licensing deal with Sanofi, CureVac has completed another tie-up, banking a $45 million upfront from Boehringer Ingelheim and partnering its therapeutic vaccine aimed at lung cancer. The deal also...
SeekingAlpha  Sep 17  Comment 
By Investing Tricks: Sanofi's (NYSE:SNY) revenues are distributed through three major segments and a large chunk is attributable to the pharmaceutical segment; 85% of revenues are attributed to the pharmaceutical segment. More than half the...
GenEng News  Sep 17  Comment 
Sanofi will join with MyoKardia to discover and develop targeted therapies for genetic cardiomyopathies based on research by the precision medicine biotech, in a deal that could generate up to $200 million for MyoKardia, the companies said...
FiercePharma  Sep 17  Comment 
MannKind has been starved for cash, so it was huge for the California-based pharma to strike a deal with Big Pharma player Sanofi to help market its inhaled insulin Afrezza. But Sanofi has something else that can cut their costs and fatten up...
FierceBiotech  Sep 17  Comment 
Sanofi has stepped up with a $45 million down payment on a potential $200 million early-stage deal to develop new drugs for heart muscle disease. The pharma giant inked one if its rare small-biotech collaboration pacts with MyoKardia, a South San...
FierceBiotech  Sep 11  Comment 
Despite an FDA rejection and changing winds in the field of multiple sclerosis, Sanofi believes its Genzyme unit is on an upward trajectory, talking up potential deals and could-be blockbusters for its pricey acquisition.
MarketWatch  Sep 11  Comment 
Royal Bank of Scotland and Lloyds Banking Group rise after saying they plan to relocate to England in case of Scottish independence.


Very nice site!

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki